China Imposes Compulsory Recalls On Drug Companies (China)
This article was originally published in PharmAsia News
Executive SummaryChinese drug makers and related companies will be responsible for recalling defective drugs from the market, Chinese authorities announced. The new rule also sets up a three-class system of recalls, to separate the intensity of the recalls and how quickly the drugs must be recalled, according to its level of danger. The companies, distributors and medical institutes also must notify the government of any reports they receive of adverse reactions to their products. The new plan gives the government authority to issue the recall itself and to punish a company that breaks the rule. (Click here for more ) "China Launches Nationwide System To Recall Harmful Drugs" China Post (12/13/07)
You may also be interested in...
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.
Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.
Israel-based Binah.ai hopes to earn regulatory approval for a video-based monitoring app that can detect vital signs in minutes. See what Binah.ai's co-founder and CEO, David Maman, said about the technology here.